Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)

Diabetes Metab J. 2011 Apr;35(2):190-1. doi: 10.4093/dmj.2011.35.2.190. Epub 2011 Apr 30.
No abstract available